Abstract
Human herpesvirus type 8 (HHV-8), also known as Kaposi’s sarcoma-associated herpesvirus (KSHV) is a new member of the γ-herpesvirus family. It is an unusual herpesvirus in that it carries a large number of genes that encode oncoproteins or cell signaling proteins. In addition to being the causative agent of both HIV-associated and non-HIV-associated Kaposi’s sarcoma this DNA tumor virus has been implicated in the pathogenesis of several diseases. These include multiple myeloma (MM), Waldenström’s macroglobulinemia (WM), multicentric Castleman’s disease (MCD), body cavity-based lymphoma (BCBL), and various other conditions such as sarcoidosis and pemphigus. While the causative role of the viral infection is fairly certain in the development of BCBL and multicentric Castleman’s disease, HHV-8 may act through a different mechanism to induce plasma cell malignancies. It has been suggested - though the finding is still controversial -that infection of bone marrow stromal dendritic cells by HHV-8 might be a key factor in the etiology and pathogenesis of monoclonal gammopathies. The aim of this review is to provide a short introduction into the tumorigenic potential of HHV-8 as well as to detail the available data and possible mechanisms on the involvement of this virus in different hematologic diseases.
Similar content being viewed by others
References
Agbalika F, Mariette X, Marolleau J-P, et al: Detection of human herpesvirus-8 DNA in bone marrow biopsies from patients with multiple myeloma and Waldenströms macroglobulinemia. Blood 91:4393–4394, 1998.
Alsina M, Gao SJ, Montalvo EA, et al: Increased prevalence of antibodies to Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) in patients with multiple myeloma. Blood 90 (Suppl 1):87a, 1997.
Arvanikatis L, Mesri EA, Nador RG, et al: Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring Kaposi’s sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus. Blood 88:2648–2654, 1996.
Asuo H, Said JW, Yang R, et al: Mechanisms of growth control of Kaposi’s sarcoma-associated herpesvirus-associated primary effusion lymphoma cells. Blood 91:2475–2481, 1998.
Bais C, Santomasso B, Coso O, et al: G-protein-coupled receptor of Kaposi’s sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 391:86–89, 1998.
Brooks LA, Wilson AJ and Crook T: Kaposi’s sarcoma-associated herpesvirus (KSHV) / Human herpesvirus 8 (HHV-8) - A new human tumor virus. J Pathol 182:262–265, 1997.
Brousset P, Meggetto F, Attal M,et al: Kaposi’s sarcoma-associated herpesvirus infection and multiple myeloma. Science 278:1972–1973, 1997.
Brousset P, Theriault C, Roda D, et al: Kaposi’s sarcoma-associated herpesvirus (KSHV) in bone marrow biopsies of patients with Waldenstroms macroglobulinemia. Br J Haematol 102:795–797, 1998.
Burger R, Neipel F, Fleckenstein B, et al: Human herpesvirus type 8 interleukin-6 homologue is functionally active on human myeloma cells. Blood 91:1858–1863, 1998.
Cathomas G, Stalder A and Kurrer MO: Multiple myeloma and HHV8 infection. Blood 91:4391, 1998.
Cheng EH-Y, Nicholas J, Bellows DS, et al: A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc Natl Acad Sci USA 94:690–694, 1997.
DeGreef C, Bakkus M, Heirman C, et al: The absence of Kaposi sarcoma-associated herpesvirus (KSHV) DNA sequences in leukapheresis products and ex vivo expanded CD34+ cells in multiple myeloma (MM) patients. Blood 90 (Suppl 1):86a, 1997.
DePond W, Said JW, Tasaka T, et al: Kaposi sarcoma-associated herpesvirus and human herpesvirus 8 (KSHV/HHV-8)-associated lymphoma of the bowel. Am J Surg Pathol 21:719–724, 1997.
DiAlberti L, Piattelli A, Artese L, et al: Human herpesvirus 8 variants in sarcoid tissues. Lancet 350:1655–1661, 1997.
Flore O, Rafii S, Ely S, et al: Transformation of primary human endothelial cells by Kaposi’s sarcoma-associated herpesvirus. Nature 394:588–592, 1998.
Gao SJ, Alsina M, Deng JH, et al: Antibodies to Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) in patients with multiple myeloma. J Infect Dis 178:846–849, 1998.
Gessain A, Sudaka A, Briere J, et al: Kaposi sarcoma-associated herpes-like virus (human herpesvirus type 8) DNA sequences in multicentric Castlemans disease: Is there any relevant association in non-human immunodeficiency virus-infected patients? Blood 87:414–416, 1996.
Gura T: Causing cancer by remote control? Science 276:1788–1789, 1997.
Hyjek E, Fata F, Niesvisky R, et al: Low prevalence of antibodies of Kaposi’s sarcoma-associated herpesvirus (KSHV/HHV-8) in patients with multiple myeloma. Blood 90 (Suppl 1):87a, 1997.
Kikuta H, Itakura O, Taneichi K, et al: Tropism of human herpesvirus 8 for peripheral blood lymphocytes in patients with Castlemans disease. Br J Haematol 99:790–793, 1997.
Lee H, Veazey R, Williams K, et al: Deregulation of cell growth by the K1 gene of Kaposi’s sarcoma-associated herpesvirus. Nat Med 4:435–440, 1998.
Lee H, Guo J, Li M, et al: Identification of an immunoreceptor tyrosine-based activation motif of K1 transforming protein of Kaposi’s sarcoma-associated herpesvirus. Mol Cell Biol 18:5219–5228, 1998.
Lennette ET, Blackburn DJ and Levy JA: Antibodies to human herpesvirus type 8 in the general population and in Kaposi’s sarcoma patients. Lancet 348:858–861, 1996.
MacKenzie J, Sheldon J, Morgan G, et al: HHV-8 and multiple myeloma in the UK. Lancet 350:1144, 1997.
Marcelin A-G, Dupin N, Bouscary D, et al: HHV-8 and multiple myeloma in France. Lancet 350:1144, 1997.
Moore SP, Boshoff C, Weiss RA, et al: Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274:1739–1743, 1996.
Muralidhar S, Pumfery AM, Hassani M, et al: Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi’s sarcoma associated herpesvirus) transforming gene. J Virol 72:4980–4988, 1998.
Nador RG, Cesarman E, Chadburn A, et al: Primary effusion lymphoma: A distinct clinicopathologic entity associated with the Kaposi’s sarcoma-associated herpesvirus. Blood 88:645–656, 1996.
Parravicini C, Corbellino M, Paulli M, et al: Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castlemans disease. Am J Pathol 151:1517–1521, 1997.
Rabkin CS, Schultz TF, Whitby D, et al: Interassay correlation of human herpesvirus 8 serologic tests. HHV-8 Interlaboratory Collaborative Group. J Infect Dis 178:304–309, 1998.
Rettig MB, Ma HJ, Vescio RA, et al: Kaposi’s sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science 276:1851–1854, 1997.
Rettig M, Vescio R, Ma H, et al: Detection of Kaposi’s sarcoma-associted herpesvirus in the dendritic cells of Waldenströms macroglobulinemia and primary amyloidosis patients. Blood 90 (Suppl 1):86a, 1997.
Rettig M, Vescio R, Ma H, et al: Sequence variability of HHV-8 from the dendritic cells of multiple myeloma patients. Blood 90 (Suppl 1):86a, 1997.
Russo JJ, Bohenzky RA, Chien M-C, et al: Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV-8). Proc Natl Acad Sci USA 93:14862–14867, 1996.
Said JW, Rettig MR, Heppner K, et al: Localization of Kaposi’s sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma. Blood 90:4278–4282, 1997.
Schultz TF: Kaposi’s sarcoma-associated herpesvirus (human herpesvirus-8). J Gen Virol 79:1573–1591, 1998.
Smith KJ, et al: Human herpesvirus 8 DNA sequences in pemphigus: The role of the virus in oncogenic and autoimmune manifestations. Arch Dermatol 134:751–754, 1998.
Swanton C, Mann DJ, Fleckenstein B, et al: Herpes viral cyclin / Cdk6 complexes evade inhibition by CDK inhibitor proteins. Nature 390:184–187, 1997.
Tarte K, Olsen SJ, Lu ZY, et al: Clinical-grade functional dendritic cells from patients with multiple myeloma are not infected with Kaposi’s sarcoma-associated herpesvirus. Blood 91:1852–1857, 1998.
Weiss RA, Whitby D, Talbot S, et al: Human herpesvirus type 8 and Kaposi’s sarcoma. J Natl Cancer Inst Monogr 23:51–54, 1998.
Yi Q, Ekman M, Anton D, et al: Blood dendritic cells from myeloma patients are not infected with Kaposi’s sarcoma-associated herpesvirus (KSHV/HHV-8). Blood 92:402–404, 1998.
Zimring JC, Goodburn S and Offerman MK: Human herpesvirus encodes an interferon regulatory factor (IRF) homolog that represses IRF-1 mediated transcription. J Virol 72:701–707, 1998.
Author information
Authors and Affiliations
Additional information
This work was supported in part by grants from the “Hungarian National Science Foundation (OTKA T 016978) the Hungarian Ministry of Welfare (ETT T05 263/96), and FNK (HIETE, Budapest)
Rights and permissions
About this article
Cite this article
Mikala, G., Xie, J., Berencsi, G. et al. Human Herpesvirus 8 in Hematologic Diseases. Pathol. Oncol. Res. 5, 73–79 (1999). https://doi.org/10.1053/paor.1999.0073
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1053/paor.1999.0073